Chemotherapy Induced Anemia Market Scope
Chemotherapy is the cancer treatment given to patients with different forms of cancer. Anemia is a condition of a decrease in the total amount of red blood cells or hemoglobin in the blood. Hemoglobin is an essential part of the red blood cells and binds oxygen. In the case of low or abnormal red blood cells, the cells in the body will not receive the appropriate amount of oxygen. Chemotherapy-induced anemia is primarily due to chemotherapy, which delays or limits the progression of treatment, and contributes significantly to both fatigue and diminished quality of life. In the United States, patients with chemotherapy-induced anemia are treated with erythropoiesis-stimulating agents namely epoetin & darbepoetin.
The Chemotherapy Induced Anemia market study is segmented and major geographies with country level break-up.
Pfizer Inc. (United States), Tolero Pharmaceuticals, Inc. (United States), FibroGen Inc. (United States), Vifor Pharma AG (Switzerland), Orphan Biovitrum AB (Switzerland), Therapure Biopharma Inc. (Canada), SBI Pharmaceuticals Co., Ltd. (Japan), Panacea Biotec Limited (India), Dr. Reddy’s Laboratories Ltd. (India), Zydus Cadila (India) and 3SBio Inc. (China) are some of the key players that are part of study coverage.
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AdvanceMarketAnalytics has segmented the market of Global Chemotherapy Induced Anemia market by Type, Application and Region.
On the basis of geography, the market of Chemotherapy Induced Anemia has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
In 2019, Swedish Orphan Biovitrum AB (Sobi) acquired Dova Pharmaceuticals, Inc. This includes outstanding shares of Dova for USD 27.50 per share, net to the seller thereof in cash, without interest and subject to any applicable withholding taxes, plus one non-transferable Contingent Value Right (CVR) which entitles Dova shareholders to an additional USD 1.50 per share upon approval of Doptelet for use in Chemotherapy-Induced Thrombocytopenia by the US Food and Drug Administration.
In 2019, FibroGen Inc. has announced the first patient dosed in the company’s phase 2 clinical study of Roxadustat, a first in class hypoxia-inducible factor prolyl hydroxylase inhibitor, for the treatment of CIA in cancer patients receiving chemotherapy.
- Growing Awareness Regarding CIA, Its Demand for Early Recognition, Prevention, and Prompt Treatment
- Increasing Availability of Chemotherapy Agents in the Developed As Well As Developing Region
- Innovation in Identification Technology of CIA and Favorable Government Policies
- Lower Efficacy of the Treating Drugs Resulting in the Decreased Patient Compliance
- Approval for Drug and Technology from the Regulatory Bodies
Key Target AudienceChemotherapy Induced Anemia Drug Manufacturers, Raw Material Suppliers, Research Institutes, Healthcare Organization, End-Use Industry and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase